Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated

C Mueller1, F-J Neumann, A P Perruchoud

  • 1Herz-Zentrum, Bad Krozingen, Germany. chmueller@uhbs.ch

Insights

Reduced kidney function significantly increases mortality risk in unstable angina/non-ST elevation acute myocardial infarction (UA/NSTEMI) patients undergoing early invasive treatment. This highlights the importance of assessing renal function for better patient outcomes.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Medicine

Background:

  • Unstable angina/non-ST elevation acute myocardial infarction (UA/NSTEMI) is a critical cardiovascular condition.
  • Early invasive strategies, including coronary angiography and stenting, are standard treatments for UA/NSTEMI.
  • The influence of baseline renal function on outcomes in these patients requires further quantification.

Purpose of the Study:

  • To determine the impact of baseline renal function on in-hospital and long-term mortality.
  • To investigate mortality in UA/NSTEMI patients treated with a very early invasive strategy.
  • To stratify mortality risk based on calculated glomerular filtration rate (GFR).

Main Methods:

  • Prospective cohort study of 1400 UA/NSTEMI patients.
  • Coronary angiography and primary stenting within 24 hours of admission.
  • Stratification of patients based on admission calculated glomerular filtration rate (GFR).

Main Results:

  • In-hospital mortality rates increased with declining GFR (0% for GFR >130 to 5.1% for GFR <60 ml/min/1.73 m2).
  • Three-year survival rates were significantly lower for patients with GFR <60 ml/min/1.73 m2 (76.8%).
  • A GFR <60 ml/min/1.73 m2 was a fourfold independent predictor of in-hospital and long-term mortality.

Conclusions:

  • Baseline renal function is a critical independent predictor of mortality in UA/NSTEMI patients.
  • Early invasive treatment strategies do not negate the prognostic importance of renal function.
  • Assessing GFR is crucial for risk stratification and management of UA/NSTEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...